AbbVie (ABBV) News Today → This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad) Free ABBV Stock Alerts $181.97 +1.62 (+0.90%) (As of 03/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAbbVie (NYSE:ABBV) Trading 0.4% Higher Following Analyst Upgradeamericanbankingnews.com - March 29 at 2:42 AMFranklin Street Advisors Inc. NC Has $29.72 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV)marketbeat.com - March 28 at 8:51 PMAldeyra gains on plans for AbbVie-partnered eye disease drugmsn.com - March 28 at 2:17 PMAbbVie (NYSE:ABBV) Stock Price Up 0.4% on Analyst Upgrademarketbeat.com - March 28 at 11:49 AMLong Live the Dividend Kings: 3 Top Picks to Build an Income Portfolioinvestorplace.com - March 28 at 6:00 AMAbbVie (NYSE:ABBV) Given New $195.00 Price Target at Barclaysamericanbankingnews.com - March 28 at 4:12 AMAbbVie (NYSE:ABBV) Trading 0.1% Higher on Analyst Upgradeamericanbankingnews.com - March 28 at 2:08 AM6,627 Shares in AbbVie Inc. (NYSE:ABBV) Bought by Trueblood Wealth Management LLCmarketbeat.com - March 27 at 11:37 PMLANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABPbusinesswire.com - March 27 at 6:04 PMHabitat for Humanity International and AbbVie celebrate successes of five-year partnership in Puerto Ricofinance.yahoo.com - March 27 at 12:34 PMAbbVie: An Undervalued Giantfinance.yahoo.com - March 27 at 12:34 PMAbbVie (NYSE:ABBV) Trading 0.1% Higher Following Analyst Upgrademarketbeat.com - March 27 at 11:23 AMAbbVie (NYSE:ABBV) Price Target Raised to $195.00 at Barclaysmarketbeat.com - March 27 at 8:29 AMAbbVie (NYSE:ABBV) and Ono Pharmaceutical (OTCMKTS:OPHLY) Head to Head Analysisamericanbankingnews.com - March 27 at 4:12 AMTrust Co of the South Purchases New Shares in AbbVie Inc. (NYSE:ABBV)marketbeat.com - March 26 at 7:54 PMAbbVie acquisition signals confidence in small-cap biotech sector's growth potentialproactiveinvestors.com - March 26 at 2:54 PMAbbVie (NYSE:ABBV) Shares Up 0.3%marketbeat.com - March 26 at 1:34 PMAbbVie (NYSE:ABBV) Trading Up 0.1% Following Analyst Upgradeamericanbankingnews.com - March 26 at 1:30 AMLandos Biopharma Shares Surge 178% on Takeover Deal With AbbViemarketwatch.com - March 25 at 9:41 PMAbbVie in Deal to Acquire Landos Biopharma for $137.5Mmarketwatch.com - March 25 at 9:41 PMLandos shares rocket 170% on AbbVie takeover dealmsn.com - March 25 at 9:41 PMAbbVie to bolster immunity illness drug pipeline with Landos dealmsn.com - March 25 at 9:41 PMAssenagon Asset Management S.A. Purchases 1,433,236 Shares of AbbVie Inc. (NYSE:ABBV)marketbeat.com - March 25 at 5:26 PMNIMML Institute's TITAN-X A.I.-Powered Precision Medicine Platform Validated through AbbVie's Acquisition of Landos Biopharma and Lead Clinical Candidate NX-13businesswire.com - March 25 at 12:40 PMAbbVie to buy Landos to expand pipeline of immunity-related illnessesreuters.com - March 25 at 8:39 AMAbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseasesprnewswire.com - March 25 at 8:31 AMAbbVie Inc. (NYSE:ABBV) Shares Acquired by Raymond James Financial Services Advisors Inc.marketbeat.com - March 24 at 10:14 PMNvidia's AI Tech Part of Novo Nordisk's New Supercomputer (ABBV)marketbeat.com - March 24 at 1:53 PMAbbVie (NYSE:ABBV) Shares Up 0.2% Following Analyst Upgradeamericanbankingnews.com - March 24 at 5:42 AMAbbVie (NYSE:ABBV) Stock Price Up 0.2% After Analyst Upgradeamericanbankingnews.com - March 24 at 4:54 AMNicholas Donoghoe Sells 21,082 Shares of AbbVie Inc. (NYSE:ABBV) Stockamericanbankingnews.com - March 24 at 4:08 AMAldeyra: Derisked Biotech Eyeing Path To Approval And Finalizing Deal With AbbVieseekingalpha.com - March 24 at 2:03 AMCHICAGO TRUST Co NA Sells 7,028 Shares of AbbVie Inc. (NYSE:ABBV)marketbeat.com - March 23 at 8:21 PMAbbVie: U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patientsfinanznachrichten.de - March 23 at 10:27 AMAbbVie Inc. (NYSE:ABBV) EVP Sells $3,716,756.60 in Stockinsidertrades.com - March 23 at 8:35 AMAbbVie (NYSE:ABBV) Given New $190.00 Price Target at Guggenheimamericanbankingnews.com - March 23 at 5:42 AMRockline Wealth Management LLC Invests $4.39 Million in AbbVie Inc. (NYSE:ABBV)marketbeat.com - March 22 at 9:48 PMThe Latest Analyst Ratings For AbbViemarkets.businessinsider.com - March 22 at 7:25 PMFDA grants full approval to AbbVie/ImmunoGen drug Elaheremsn.com - March 22 at 7:25 PMAbbVie’s New ‘Biological Missile’ Ovarian Cancer Treatment Gets Full FDA Approvalmsn.com - March 22 at 7:25 PMUPDATE 1-US FDA grants full approval to AbbVie's ovarian cancer therapyfinance.yahoo.com - March 22 at 7:25 PMInsider Sell: EVP, Chief Business/Strategy Officer Nicholas Donoghoe Sells 21,082 Shares of ...finance.yahoo.com - March 22 at 7:25 PMU.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE® (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patientsprnewswire.com - March 22 at 3:02 PMAbbVie (NYSE:ABBV) Price Target Raised to $190.00marketbeat.com - March 22 at 2:59 PMUS FDA grants full approval to AbbVie's ovarian cancer therapyreuters.com - March 22 at 2:38 PMAbbVie (NYSE:ABBV) Stock Price Up 0.2%marketbeat.com - March 22 at 1:41 PMJeffrey Ryan Stewart Sells 58,949 Shares of AbbVie Inc. (NYSE:ABBV) Stockamericanbankingnews.com - March 22 at 4:32 AMAbbVie Inc. (NYSE:ABBV) Shares Purchased by Clarity Financial LLCmarketbeat.com - March 21 at 5:17 PMAbbVie (NYSE:ABBV) Trading 0.6% Higher marketbeat.com - March 21 at 4:28 PMCyndeo Wealth Partners LLC Purchases 10,863 Shares of AbbVie Inc. (NYSE:ABBV)marketbeat.com - March 21 at 1:53 PM Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address Warning: this could blow your mind (Ad)Buckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting… Watch the presentation here ABBV Media Mentions By Week ABBV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABBV News Sentiment▼0.590.61▲Average Medical News Sentiment ABBV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABBV Articles This Week▼4921▲ABBV Articles Average Week Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MRK News Today JNJ News Today PFE News Today BMY News Today IQV News Today IDXX News Today SGEN News Today MRNA News Today BNTX News Today ILMN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABBV) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the MarketsBill Gates is all about this tiny $2 stockTimothy SykesThe 3rd Revolution in WarfareWeiss RatingsFed launches fourth dollar overhaulStansberry ResearchAI to Meet the Same Fate as EVs? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.